After safety concerns in phase III of its GLP-1 analog taspoglutide, Roche got back into the obesity market by acquiring Carmot Therapeutics in 2024
We're paralleling that with our robust injectable investments and if we're wrong, okay, we'll have to eat thatif orforglipron isn't a strong product, he continued
Irfan Khan, MD , provides expert evaluations to determine if Ozempic is right for you
Results Study participants characteristics The study participants constituted a homogeneous group of 24 healthy males with normal BMI (22.9 1.6 kg/ m 2 , mean SD), HbA1c (33.7 2.2 mmol/mol) and fasting blood glucose levels (4.8 0.4 mmol/L) (Table 1)
Adjei AA, Gaedigk A, Simon SD, Weinshilboum RM, Leeder JS: Interindividual variability in acetaminophen sulfation by human fetal liver: implications for pharmacogenetic investigations of drug-induced birth defects